2 recruiting, 1 active not recruiting, 1 enrolling by invitation, 1 not yet recruiting. 3 Not applicable, 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 3 | Enrolling by invitation 1, Not yet recruiting 1, Recruiting 1 |
| Phase 1 | 1 | Recruiting 1 |
| Phase 2 | 1 | Recruiting 1 |
Follow Ruihua Wei: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Control of Myopia in Young Children Using H.O.P.E. Lenses Combined With 0.02% Atropine Eye Drops High-order Phase Element Array Microstructure Design Lens (H.O.P.E.), 0.02% Atropine Sulfate Eye Drops - Myopia | Not applicable | Not yet recruiting | Ruihua Wei | 264 | 2026-09-30 | 2026-09-29 |
| Repeatability of AO-SLO (Mona IIa) Technology and Cone Cell Density of Individuals Use Repeated Low-level Red-light Therapy RLRL(Model RS-200-2A, Eyerising; Suzhou Xuanjia Optoelectronic Technology Co., Ltd., Suzhou, China)) - Myopia | Not applicable | Recruiting | Ruihua Wei | 180 | 2025-09-20 | 2025-09-15 |
| Therapeutic Efficacy of Different Repeated Low-Intensity Red Light Devices and Different Usage Frequencies Eyerising RS-200-2A, Eyerising SLX-1A - Myopia | Not applicable | Enrolling by invitation | Ruihua Wei | 60 | 2025-09-20 | 2026-10-29 |
| Atropine (0.02%, 0.04%) Combined With Defocus DIMS for Moderate and High Myopia Control DIMS, The 0.02% ATP Group, The 0.04% ATP Group - Myopia | Phase 1 / Phase 2 | Recruiting | Ruihua Wei | 410 | 2024-02-01 | 2025-09-08 |
| Efficacy and Influencing Factors of Repeated Low-level Red-light in Myopia Red Light - Myopia | Active not recruiting | Ruihua Wei | 3000 | 2020-09-28 | 2025-09-08 |
Myopia (5)
China (5)